Epidemiological aspects of human papillomavirus infection and cervical cancer in Brazil

Journal of Infection

Volumn 40, Issue 1, 2000, Pages 80-87

  Cavalcanti, Sílvia M B ^a   Zardo, Lucília G ^b   Passos, Ledy H S ^a   Oliveira, Ledy H S ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CANCER RISK; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PREVALENCE; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; SYPHILIS; TOBACCO; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 0034017371     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.1999.0596     Document Type: Article

References (37)

1. De Villiers E. M. Heterogeneity of human papillomavirus group. J Virol. 63:1989;4898-4903.
2. Schiffman M. H. Epidemiology of cervical human papillomavirus infections. Cur Microbiol Immunol. 186:1994;56-78.
3. Woodworth C. D., Doniger J., Di Paolo J. A. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs correspond to their association with cervical carcinoma. J Virol. 63:1989;159-164.
4. Syrjanen K. J. Epidemiology of human papillomavirus (HPV) infections and their association with genital squamous cell cancer. APMIS. 97:1989;957-970.
5. Lowy D. R., Kirnbauer R., Schiller J. T. Genital human papillomavirus infection. Proc Nat Acad Sci USA. 91:1994;2436-2440.
6. Fisher S. G. Epidemiology: a tool for the study of Human Papillomavirus - related carcinogenesis. Intervirology. 37:1994;215-225.
7. INCa (Pro-Onco), Ministério da Saúde, Brasil. 1992; 1985/1991. 1992.
8. Noronha V., Mello W., Villa L., Brito A., Macedo R., Mota R., Monteiro T., Linhares A. Papilomavírus humano associado a lesões de cérvice uterina. Rev Soc Bras Medicina Trop. 32:1999;235-250.
9. Cavalcanti S. M. B., Deus F. C. C., Zardo L. G., Frugulhetti I. C. P., Oliveira L. H. S. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study. Mem Inst Oswaldo Cruz. 91:1996;433-440.
10. Villa L. L. Human papillomavirus and cervical cancer. Adv Cancer Res. 71:1997;321-341.
11. Acta Cytol. 37:1993;115-124.
12. Cavalcanti S. M. B., Frugulhetti I. C. P., Passos M. R. L., Fonseca M. E. F., Oliveira L. H. S. Prevalence of human papillomavirus DNA in female cervical lesions from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 89:1994;575-580.
13. Syrjanen S. M. Basic concepts and practical applications of recombinant DNA techniques in the detection of human papillomavirus (HPV) infections. APMIS. 98:1990;95-110.
14. Yun K., Sherwood M. J. In situ hybridization at light and electron microscopic levels: identification of human papillomavirus nucleic acids. Pathol. 24:1992;91-98.
15. Young L. S., Bevan I. S., Jonhson M. A., Blomfield P. I., Bromigde T., Maitland N. J., Woodman C. B. J. The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ. 298:1989;14-18.
16. Lie E. S., Heyden A., Johannesen M. K., Boysen M., Brandtzaeg P. Detection of human papillomavirus in routinely processed biopsy specimens from laryngeal papillomas: evaluation of reproducibility of polymerase chain reaction and DNA in situ hybridization procedures. Acta Otolaryng (Stockh). 116(:1996;627-632.
17. Kiviat N. B., Koutsky L. A., Paavonen J. A. Prevalence of genital papillomavirus infection among women attending a college student clinic or a sexually transmitted disease clinic. J Infec Dis. 159:1989;293-302.
18. Reid R., Greenberg M., Jenson A. B., Stanhope R., Hershman V. R., Smith J. P., Lancaster W. D. Sexually transmitted papillomavirus infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral tyes. Am J Obstet Gynecol. 156:1987;212-222.
19. Muñoz N., Bosch F. X., Sanjosé S. El virus del papiloma humano en la etiologia del cancer cervicouterino. Boletin de la Oficina Sanitaria Panamericana. 115:1993;301-308.
20. Bosch F. X., Muñoz N., Sanjosé S. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer. 52:1992;750-758.
21. Kataja V., Syrjanen S., Mantijarvi R. Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis. 19:1992;154-160.
22. Kristiansen E., Jenkins A., Kristiansen G. Human papillomavirus infection in Norwegian women with cervical cancer. APMIS. 102:1994;122-128.
23. Burger R. A., Monk B. J., Kurosaki T. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst. 88:1996;1361-1368.
24. Barnes W., Woodworth C., Wagooner S. Rapid dysplastic transformation of human genital cells by human papillomavirus type 18. Gynecol Oncol. 38:1990;343-346.
25. Walker J., Bloss J. D., Liao S. Y., Berman M., Berhen S., Wilczynski S. P. Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol. 74:1989;781-785.
26. Villa L. L., Lopes A. Human papillomavirus DNA sequences in Penile carcinomas in Brazil. Int J Cancer. 37:1989;853-855.
27. Ho G. Y. F., Burk R. D., Fleming I., Klein R. S. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer. 56:1994;788-792.
28. Meekin G. E., Sparrow M. J., Fernwicke R. J., Tobias M. Prevalence of genital human papillomavirus infection in Wellington women. Genitorin Med. 68:1992;228-232.
29. Sanjosé S., Muñoz N., Bosch F. X. Sexually transmitted agents and cervical neoplasia in Columbia and Spain. Int J Cancer. 56:1994;358-363.
30. Stern E., Forsythe A. B., Youkles L., Coffelt C. F. Steroid contraceptive use and cervical cancer: increased risk of progression. Science. 196:1977;1460-1463.
31. Davidson M., Schnitzer P. G., Bulkow L. R. The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska native women. J Infect Dis. 169:1994;792-800.
32. Vessey M. P. Epidemiology of cervical cancer: role of hormonal factors, cigarette smoking and occupation. Banbury Report Series. 21:1986;29-43.
33. Van Doornum G. J. J., Van den Hoek J. A. R., Van Ameijden E. J. C. Cervical HPV infection among HIV-infected prostitutes addicted to hard drugs. J Med Virol. 41:1993;185-190.
34. Eluf-Neto J., Booth M., Muñoz N., Bosch F., Meijer C. L. M., Walboomers J. M. Human papillomavirus and invasive cervical cancer in Brazil. Brit J Cancer. 69:1994;114-119.
35. Vandenvelde C., Van Beers D. High risk genital papillomaviruses and degree of dysplastic changes in the cervix. J Med Virol. 39:1993;273-277.
36. Brentani M. M. Carcinogênese química. Brentani M. M., Coelho F. R.G., Iyeyasu H., Kowalski L. P. Bases da Oncologia. 1998;157-172 Lemar SP, Brazil.
37. Passos, M. R.L. Imunologia das DSTs. Passos, M. R.L. Doenças Sexualmente Transmissíveis, 215, 238, Cultura Médica RJ, Brazil.